Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $46000.0.

  • Upstream Bio's Depreciation & Amortization (CF) rose 22857.14% to $46000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $180000.0, marking a year-over-year increase of 23333.33%. This contributed to the annual value of $89000.0 for FY2024, which is 4833.33% up from last year.
  • Per Upstream Bio's latest filing, its Depreciation & Amortization (CF) stood at $46000.0 for Q3 2025, which was up 22857.14% from $42000.0 recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Depreciation & Amortization (CF) registered a high of $49000.0 during Q4 2024, and its lowest value of $13000.0 during Q1 2024.
  • For the 3-year period, Upstream Bio's Depreciation & Amortization (CF) averaged around $29250.0, with its median value being $28000.0 (2023).
  • As far as peak fluctuations go, Upstream Bio's Depreciation & Amortization (CF) soared by 25000.0% in 2024, and later soared by 22307.69% in 2025.
  • Over the past 3 years, Upstream Bio's Depreciation & Amortization (CF) (Quarter) stood at $14000.0 in 2023, then soared by 250.0% to $49000.0 in 2024, then decreased by 6.12% to $46000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $46000.0 for Q3 2025, versus $42000.0 for Q2 2025 and $43000.0 for Q1 2025.